Journal of Thrombosis and Haemostasis

The tissue factor-factor VIIa complex: procoagulant activity, regulation, and multitasking
pp. 1097-1105(9)
Authors: MONROE, D. M.; KEY, N. S.

The intrinsic pathway of coagulation: a target for treating thromboembolic disease?
pp. 1106-1112(7)
Authors: GAILANI, D.; RENNÉ, T.

von Willebrand disease: treatment with or without factor VIII?
pp. 1113-1114(2)
Author: KONKLE, B. A.

Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin^®): a prospective study of 50 patients
pp. 1115-1124(10)
Authors: BOREL-DERLON, A.; FEDERICI, A. B.; ROUSSEL-ROBERT, V.; GOUDEMAND, J.; LEE, C. A.; SCHARRER, I.; ROTHSCHILD, C.; BERNTORP, E.; HENRIET, C.; TELLIER, Z.; BRIDEY, F.; MANNUCCI, P. M.

Inflammatory/hemostatic biomarkers and cardiovascular risk: coming of age?
pp. 1125-1127(3)
Author: LOWE, G. D. O.

Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study
pp. 1128-1135(8)
Authors: ZAKAI, N. A.; KATZ, R.; JENNY, N. S.; PSATY, B. M.; REINER, A. P.; SCHWARTZ, S. M.; CUSHMAN, M.

The bloody path of amyloids and prions
pp. 1136-1138(3)
Authors: HAMMARSTRÖM, P.

Increased plasmin-α2-antiplasmin levels indicate activation of the fibrinolytic system in systemic amyloidoses
pp. 1139-1142(4)
Authors: BOUMA, B.; MAAS, C.; HAZENBERG, B. P. C.; LOKHORST, H. M.; GEBBINK, M. F. B. G.

Evidence of a U-shaped association between factor XII activity and overall survival
pp. 1143-1148(6)
Authors: ENDLER, G.; MARSIK, C.; JILMA, B.; SCHICKBAUER, T.; QUEHENBERGER, P.; MANNHALTER, C.

Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers
pp. 1149-1157(9)
Authors: SABBÀ, C.; PASCULLI, G.; LENATO, G. M.; SUPPRESSA, P.; LASTELLA, P.; MEMEO, M.; DICUONZO, F.; GUANTI, G.

Anti-prothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus: a 15-year longitudinal study
pp. 1158-1164(7)
Authors: BIZZARO, N.; GHIRARDELLO, A.; ZAMPIERI, S.; IACCARINO, L.; TOZZOLI, R.; RUFFATTI, A.; VILLALTA, D.; TONUTTI, E.; DORIA, A.

Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease
pp. 1165-1169(5)
Authors: JAMES, A. H.; JAMISON, M. G.

Oxidative stress-mediated platelet CD40 ligand upregulation in patients with hypercholesterolemia: effect of atorvastatin
pp. 1170-1178(9)
Authors: PIGNATELLI, P.; SANGUIGNI, V.; LENTI, L.; LOFFREDO, L.; CARNEVALE, R.; SORGE, R.; VIOLI, F.

Role of elevated α₂-macroglobulin revisited: results of a case-control study in children with symptomatic thromboembolism
pp. 1179-1184(6)
Authors: BEHEIRI, A.; LANGER, C.; DÜRING, C.; KRÜMPEL, A.; THEDIECK, S.; NOWAK-GÖTTL, U.

High risk for venous thromboembolism in diabetics with hyperosmolar state: comparison with other acute medical illnesses
pp. 1185-1190(6)
Authors: KEENAN, C. R.; MURIN, S.; WHITE, R. H.

Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials
pp. 1191-1194(4)
Authors: DAVIDSON, B. L.; BÜLLER, H. R.; DECOUSUS, H.; GALLUS, A.; GENT, M.; PIOVELLA, F.; PRINS, M. H.; RASKOB, G. E.; SEGERS, A. E. M.; LENSING, A. W. A.

A novel anti-ischemic nitric oxide donor (LA419) reduces thrombogenesis in healthy human subjects
pp. 1195-1200(6)
Authors: Zafar, M. U.; VILAHUR, G.; CHOI, B. G.; IBANEZ, B.; VILES-GONZALEZ, J. F.; SALAS, E.; BADIMON, J. J.

Postmenopausal oral estrogen therapy affects hemostatic factors, but does not account for reduction in the progression of subclinical atherosclerosis
pp. 1201-1208(8)
Authors: VIGEN, C.; HODIS, H. N.; CHANDLER, W. L.; LOBO, R. A.; MACK, W. J.

Left ventricular systolic dysfunction is an independent predictor of homocysteine in angiographically documented patients with or without coronary artery lesions
pp. 1209-1216(8)
Authors: GUÉANT-RODRIGUEZ, R.-M.; JUILLIÈRE, Y.; NIPPERT, M.; ABDELMOUTTALEB, I.; HERBETH, B.; ALIOT, E.; DANCHIN, N.; GUÉANT, J.-L.

Enhanced peripheral thrombogenicity after lung inflammation is mediated by platelet-leukocyte activation: role of P-selectin
pp. 1217-1226(10)
Authors: NEMMAR, A.; HOET, P. H. M.; VANDERVOORT, P.; DINSDALE, D.; NEMERY, B.; HOYLAERTS, M. F.

Efficient induction of immune tolerance to coagulation factor IX following direct intramuscular gene transfer
pp. 1227-1236(10)
Authors: COHN, E. F.; ZHUO, J.; KELLY, M. E.; CHAO, H. J.

Antithrombotic and anticoagulant effects of the direct thrombin inhibitor dabigatran, and its oral prodrug, dabigatran etexilate, in a rabbit model of venous thrombosis
pp. 1237-1242(6)
Authors: WIENEN, W.; STASSEN, J.-M.; PRIEPKE, H.; RIES, U. J.; HAUEL, N.

Polymorphism 10034C>T is located in a region regulating polyadenylation of FGG transcripts and influences the fibrinogen γ′/γA mRNA ratio
pp. 1243-1249(7)
Authors: UITTE DE WILLIGE, S.; RIETVELD, I. M.; DE VISSER, M. C. H.; VOS, H. L.; BERTINA, R. M.

The relative kinetics of clotting and lysis provide a biochemical rationale for the correlation between elevated fibrinogen and cardiovascular disease
pp. 1250-1256(7)
Authors: KIM, P. Y.; STEWART, R. J.; LIPSON, S. M.; NESHEIM, M. E.

Complete inhibition of fibrinolysis by sustained carboxypeptidase B activity: the role and requirement of plasmin inhibitors
pp. 1257-1264(8)
Authors: WALKER, J. B.; BAJZAR, L.

Fibrinolysis in a lipid environment: modulation through release of free fatty acids
pp. 1265-1273(9)
Authors: RÁBAI, G.; VÁRADI, B.; LONGSTAFF, C.; SÓTONYI, P.; KRISTÓF, V.; TIMÁR, F.; MACHOVICH, R.; KOLEV, K.

Continuous expression of Bcl-xL protein during megakaryopoiesis is post-translationally regulated by thrombopoietin-mediated Akt activation, which prevents the cleavage of Bcl-xL
pp. 1274-1282(9)
Authors: KOZUMA, Y.; KOJIMA, H.; YUKI, S.; SUZUKI, H.; NAGASAWA, T.

Thrombin induces apoptotic events through the generation of reactive oxygen species in human platelets
pp. 1283-1291(9)
Authors: LOPEZ, J. J.; SALIDO, G. M.; GÓMEZ-ARTETA, E.; ROSADO, J. A.; PARIENTE, J. A.

The suppressive effect of sphingosine 1-phosphate on monocyte-endothelium adhesion may be mediated by the rearrangement of the endothelial integrins α₅β₁ and α_vβ₃
pp. 1292-1301(10)
Authors: AOKI, S.; YATOMI, Y.; SHIMOSAWA, T.; YAMASHITA, H.; KITAYAMA, J.; TSUNO, N. H.; TAKAHASHI, K.; OZAKI, Y.

The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells
pp. 1302-1308(7)
Authors: DOU, L.; JOURDE-CHICHE, N.; FAURE, V.; CERINI, C.; BERLAND, Y.; DIGNAT-GEORGE, F.; BRUNET, P.

Effect of wine phenolics on cytokine-induced C-reactive protein expression
pp. 1309-1317(9)
Authors: KAUR, G.; RAO, L. V. M.; AGRAWAL, A.; PENDURTHI, U. R.

Calibration of the WHO 1st International Standard for blood coagulation factor V in plasma, human (03/116)
pp. 1318-1319(2)
Authors: HUBBARD, A. R.; WELLER, L. J.; JOHNES, S.

Local tissue-type plasminogen activator release in patients with ischemic stroke
pp. 1320-1322(3)
Authors: JOOD, K.; JERN, C.; BLOMSTRAND, C.; JERN, S.; HRAFNKELSDÓTTIR, T.

Thalidomide causes platelet activation, which can be abrogated by aspirin
pp. 1323-1324(2)
Authors: DUNKLEY, S.; GAUDRY, L.

Linkage analysis for three coagulation factors clustering on chromosome 13q34: factor VII, factor X and protein Z
pp. 1325-1326(2)
Authors: VOSSEN, C. Y.; HASSTEDT, S. J.; DEMERS, C.; ROSENDAAL, F. R.; BOVILL, E. G.

Feasibility and accuracy of a rapid `point-of-care' D-dimer test performed with a capillary blood sample
pp. 1327-1329(3)
Authors: VAN DER VELDE, E. F.; WICHERS, I. M.; TOLL, D. B.; VAN WEERT, H. C. P. M.; BÜLLER, H. R.

Bilirubin oxidase as a solution for the interference of hyperbilirubinemia with ADAMTS-13 activity measurement by FRETS-VWF73 assay
pp. 1330-1331(2)
Authors: ECKMANN, C. M.; DE LAAF, R. T. M.; VAN KEULEN, J. M.; VAN MOURIK, J. A.; DE LAAT, B.

A comparison of anticoagulation results of patients managed with narrow vs. standard international normalized ratio target ranges
pp. 1332-1333(2)
Authors: MEIER, D. J.; SEVA, S.; FAY, W. P.

The intrinsic enzymatic activity of procarboxypeptidase U (TAFI) does not significantly influence the fibrinolysis rate: a rebuttal
pp. 1334-1336(3)
Authors: WILLEMSE, J. L.; HEYLEN, E.; HENDRIKS, D. F.

The intrinsic enzymatic activity of procarboxypeptidase U (TAFI) does not significantly influence the fibrinolytic rate: reply to a rebuttal
pp. 1336-1337(2)
Authors: VALNICKOVA, Z.; THØGERSEN, I. B.; POTEMPA, J.; ENGHILD, J. J.

A mechanism to safeguard platelet adhesion under high-shear flow: von Willebrand factor-glycoprotein Ib and integrin α₂β₁-collagen interactions make complementary, collagen-type-specific contributions to adhesion: a rebuttal
pp. 1338-1339(2)
Authors: LISMAN, T.; FARNDALE, R. W.; DE GROOT, P. G.

A mechanism to safeguard platelet adhesion under high-shear flow: von Willebrand factor-glycoprotein Ib and integrin α₂β₁-collagen interactions make complementary, collagen-type-specific contributions to adhesion: reply to a rebuttal
pp. 1340-1342(3)
Authors: MOROI, M.; JUNG, S. M.

Corrigendum
pp. 1343-1343(1)

ANNOUNCEMENTS
pp. 1344-1344(1)